Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?

Aisling E Courtney, Peter T McNamee, William E Nelson, Alexander Peter Maxwell

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)

Abstract

IgA nephropathy (IgAN) is a frequent cause of end-stage renal disease (ESRD) and recurrent disease causes deterioration and graft loss in transplant recipients. No definitive management is known to reduce the risk or severity of recurrent IgAN, and the evidence to support the use of renin-angiotensin system blockade in such patients is limited.
Original languageEnglish
Pages (from-to)3550-4
Number of pages5
JournalNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Volume21
Issue number12
DOIs
Publication statusPublished - 01 Dec 2006

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Fingerprint Dive into the research topics of 'Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?'. Together they form a unique fingerprint.

Cite this